Outcomes of Rituximab for EBV Viremia/Post-Transplant Lymphoproliferative Disease in CD34+ Selected Allogeneic Hematopoietic Stem Cell Transplantation

Autor: Poppiti, Kristen *, Lin, Andrew *, Adel, Nelly G. *, Hilden, Patrick *, Castro-Malaspina, Hugo
Zdroj: In Blood 2 December 2016 128(22):4623-4623
Databáze: ScienceDirect